210 related articles for article (PubMed ID: 32568127)
1. Facts and de facto treatment of spasticity.
Kim H; Stanford R
J Pediatr Rehabil Med; 2020; 13(2):189-193. PubMed ID: 32568127
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
3. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
6. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
Hoare BJ; Wallen MA; Imms C; Villanueva E; Rawicki HB; Carey L
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003469. PubMed ID: 20091546
[TBL] [Abstract][Full Text] [Related]
8. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.
Placzek R; Siebold D; Funk JF
Toxins (Basel); 2010 Sep; 2(9):2258-71. PubMed ID: 22069684
[TBL] [Abstract][Full Text] [Related]
9. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A in the management of upper limb spasticity in cerebral palsy.
Chin TY; Graham HK
Hand Clin; 2003 Nov; 19(4):591-600. PubMed ID: 14596551
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin A in management of children with cerebral palsy.
Friedman BC; Goldman RD
Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
15. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
16. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
17. Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
De Beukelaer N; Weide G; Huyghe E; Vandekerckhove I; Hanssen B; Peeters N; Uytterhoeven J; Deschrevel J; Maes K; Corvelyn M; Costamagna D; Gayan-Ramirez G; Van Campenhout A; Desloovere K
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202166
[TBL] [Abstract][Full Text] [Related]
18. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
19. Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.
Graham HK
Eur J Neurol; 2001 Nov; 8 Suppl 5():30-9. PubMed ID: 11851732
[TBL] [Abstract][Full Text] [Related]
20. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]